BAAR, Switzerland--(BUSINESS WIRE)--Biopartners Holdings AG today announced that it has terminated its supply agreement with The Medical House. In February 2005, The Medical House signed a 10 year supply agreement with Biopartners GmbH for the license and supply of The Medical House’s GH1 reusable, spring powered, needle-free delivery system for the delivery of Biopartners’ human growth hormone product, Valtropin®.